scispace - formally typeset
Open AccessJournal ArticleDOI

The Economic Costs of Type 2 Diabetes: A Global Systematic Review

Reads0
Chats0
TLDR
The regression analysis revealed that direct diabetes costs are closely and positively associated with a country’s gross domestic product (GDP) per capita, and that the USA stood out as having particularly high costs, even after controlling for GDP per capita.
Abstract
Background There has been a widely documented and recognized increase in diabetes prevalence, not only in high-income countries (HICs) but also in low- and middle-income countries (LMICs), over recent decades. The economic burden associated with diabetes, especially in LMICs, is less clear.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants

Bin Zhou, +497 more
- 09 Apr 2016 - 
TL;DR: In this article, the authors used a Bayesian hierarchical model to estimate trends in diabetes prevalence, defined as fasting plasma glucose of 7.0 mmol/L or higher, or history of diagnosis with diabetes, or use of insulin or oral hypoglycaemic drugs in 200 countries and territories in 21 regions, by sex and from 1980 to 2014.
Journal ArticleDOI

Gut microbial metabolites in obesity, NAFLD and T2DM.

TL;DR: The role of gut microbial metabolites derived from carbohydrate fermentation and protein fermentation in body weight control, nonalcoholic fatty liver disease, insulin resistance and type 2 diabetes mellitus is explored and the mechanisms involved are discussed.
Journal ArticleDOI

The global economic burden of diabetes in adults aged 20–79 years: a cost-of-illness study

TL;DR: The findings suggest that large diabetes-associated costs are not only a problem in high-income settings but also affect poorer world regions, and further research in low-income regions is needed.
Journal ArticleDOI

Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors

TL;DR: Specific barriers to medication adherence in T2D, especially those that are potentially modifiable, need to be more clearly identified and strategies that target poor adherence should focus on reducing medication burden and addressing negative medication beliefs of patients.
References
More filters
Journal ArticleDOI

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

TL;DR: Moher et al. as mentioned in this paper introduce PRISMA, an update of the QUOROM guidelines for reporting systematic reviews and meta-analyses, which is used in this paper.
Journal Article

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.

TL;DR: The QUOROM Statement (QUality Of Reporting Of Meta-analyses) as mentioned in this paper was developed to address the suboptimal reporting of systematic reviews and meta-analysis of randomized controlled trials.
Journal ArticleDOI

Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement

TL;DR: A structured summary is provided including, as applicable, background, objectives, data sources, study eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, conclusions and implications of key findings.
Journal ArticleDOI

Economic costs of diabetes in the US in 2002.

TL;DR: In this paper, the authors estimated the direct medical and indirect productivity-related costs attributable to diabetes and calculated and compared the total and per capita medical expenditures for people with and without diabetes.
Related Papers (5)
Trending Questions (1)
-Why Diabetes type 2 is so important? Cost to the economy? Life expectancy? Sikness, absenteeism?

Type 2 diabetes is crucial due to its increasing global prevalence. Its economic burden is significant, especially in low- and middle-income countries. Impact on life expectancy, sickness, and absenteeism is substantial.